Abstract
Background
Gastric cancer has a tendency to present at early age in the Mexican population, and it is frequently associated with a family history. A polymorphism at position −160 at the CDH1 promoter region has been reported to lead to transcriptional downregulation of the gene in vitro, with possible increase in the risk of gastric cancer. We evaluated the role of the −160A allele in the risk of gastric cancer in a young Mexican population.
Methods
Peripheral blood sample of Mexican patients younger than 45 years old with diagnosis of diffuse gastric cancer were obtained. We performed DNA extraction and analyzed the frequencies of −160 promoter polymorphism of E-cadherin gene by polymerase chain reaction–single strand conformational polymorphism. These frequencies were compared with those of healthy controls. The χ2 test for association was used to test differences of the genotype frequencies between normal controls and patients with gastric cancer. Findings were considered significant at P < .05.
Results
The frequency of the −160 A allele was significantly higher (P = .002) in 39 patients with diffuse gastric cancer compared with 78 matched controls. The odds ratio associated with the A-allele was 1.98 for C/A heterozygotes (95% CI 1.01–3.98) and 6.5 for A/A homozygotes (95% CI 2.1–19.6). We found an increased risk of diffuse gastric cancer according to family history, independent of the expression of the polymorphism.
Conclusions
The −160 C/A polymorphism of the E-cadherin has a direct effect on the risk of diffuse gastric cancer at young age in Mexican population.
Similar content being viewed by others
References
Medina-Franco H, Heslin MJ, Cortés-González R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000; 7:515–9
Ramos-De la Medina A, Salgado-Nesme N, Torres-Villalobos G, Medina-Franco H. Clinicopathological characteristics of gastric cancer in a young patient population. J Gastrointest Surg 2004; 8:240–4
Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 1994; 25:849–56
Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988; 102:639–55
Behrens J, Mareel MM, Von Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108:2435–47
Medina-Franco H, Gamboa-Dominguez A, Torres-Villalobos G, et al. Altered expression of E-cadherin predicts survival in young patients with poorly differentiated gastric adenocarcinoma. Proc Am Soc Clin Oncol 2003; 22:351
Berx G, Becker KF, Hofler H, van Roy F. Mutation of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12:226–37
Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402–5
Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000; 60:873–6
Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002; 21:8192–5
Ramos-De la Medina, More H, Medina-Franco H, et al. Single nucleotide polymorphisms (SNPs) in the promoter region of CDH1 in familial gastric cancer. Rev Esp Enferm Dig 2006; 98:36–41
Wu MS, Huang SP, Chang YT, et al. Association of the −160 C→A promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002; 94:1443–8
Park WS, Cho YG, Park JY, et al. A single nucleotide polymorphism in the E-cadherin gene promoter −160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003; 18:501–4
Pharoah PD, Oliveira C, Machado JC, et al. CDH1 c−160a promoter polymorphism is not associated with the risk of stomach cancer. Int J Cancer 2002; 101:196–7
Perera FP, Weinstein IB. Molecular epidemiology: recent advances and future directions. Carcinogenesis 2000; 21:517–24
Lei H, Sjoberg-Margolin S, Salahsor S, et al. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variations show no detectable breast cancer risk. Int J Cancer 2002; 98:199–204
Porter TR, Richards FM, Houlston RS, et al. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 2002; 21:1928–33
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Medina-Franco, H., Medina, A.RD.l., Vizcaino, G. et al. Single Nucleotide Polymorphisms in the Promoter Region of the E-cadherin Gene in Gastric Cancer: Case-Control Study in a Young Mexican Population. Ann Surg Oncol 14, 2246–2249 (2007). https://doi.org/10.1245/s10434-006-9054-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-006-9054-4